Last reviewed · How we verify
Single dose of HDM1002 on Day 1
Single dose of HDM1002 on Day 1 is a Small molecule drug developed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Single dose of HDM1002 on Day 1 |
|---|---|
| Sponsor | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement (PHASE1)
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects. (PHASE1)
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single dose of HDM1002 on Day 1 CI brief — competitive landscape report
- Single dose of HDM1002 on Day 1 updates RSS · CI watch RSS
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Single dose of HDM1002 on Day 1
What is Single dose of HDM1002 on Day 1?
Single dose of HDM1002 on Day 1 is a Small molecule drug developed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..
Who makes Single dose of HDM1002 on Day 1?
Single dose of HDM1002 on Day 1 is developed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (see full Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. pipeline at /company/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd).
What development phase is Single dose of HDM1002 on Day 1 in?
Single dose of HDM1002 on Day 1 is in Phase 1.